Farmson Basic Drugs is expanding beyond paracetamol with a growing portfolio of high-demand APIs across respiratory, cardiovascular, urology, and nutritional therapies. New offerings such as Theophylline, Mirabegron, Folic Acid, Levosalbutamol, Theobromine, and Rivaroxaban reflect Farmson’s commitment to quality, compliance, and innovation. Backed by strong R&D, scalable facilities, and global regulatory standards, this expansion enables customers to source multiple critical APIs from one trusted partner.
For More Information Visit: https://www.farmson.com/blogs/expanding-the-api-portfolio-farmsons-new-api-offerings/
No comments:
Post a Comment